RIM
TMO icon

Reliant Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Reliant Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.04M Sell
12,047
-48
-0.4% -$23K 2.15% 20
2026
Q1 		$5.95M Buy
12,095
+135
+1% +$73.3K 2.87% 19
2025
Q4 		$6.93M Sell
11,960
-745
-6% -$421K 2.81% 14
2025
Q3 		$6.16M Sell
12,705
-491
-4% -$229K 2.34% 21
2025
Q2 		$5.35M Buy
13,196
+860
+7% +$360K 2.32% 25
2025
Q1 		$6.14M Buy
12,336
+90
+0.7% +$48.7K 3.19% 12
2024
Q4 		$6.37M Buy
12,246
+200
+2% +$110K 2.81% 11
2024
Q3 		$7.45M Sell
12,046
-117
-1% -$69.3K 3.5% 8
2024
Q2 		$6.73M Sell
12,163
-10
-0.1% -$5.73K 3.17% 7
2024
Q1 		$7.08M Buy
12,173
+80
+0.7% +$44.9K 3.32% 8
2023
Q4 		$6.42M Sell
12,093
-71
-0.6% -$34.4K 3.27% 9
2023
Q3 		$6.16M Sell
12,164
-223
-2% -$119K 3.59% 7
2023
Q2 		$6.46M Buy
12,387
+366
+3% +$198K 3.72% 5
2023
Q1 		$6.93M Sell
12,021
-902
-7% -$508K 4.37% 3
2022
Q4 		$7.12M Sell
12,923
-606
-4% -$321K 4.24% 3
2022
Q3 		$6.86M Sell
13,529
-145
-1% -$81.1K 4.88% 1
2022
Q2 		$7.43M Sell
13,674
-575
-4% -$316K 5.22% 1
2022
Q1 		$8.42M Sell
14,249
-120
-0.8% -$68.9K 4.32% 2
2021
Q4 		$9.59M Sell
14,369
-455
-3% -$284K 3.94% 2
2021
Q3 		$8.47M Sell
14,824
-600
-4% -$329K 4.22% 3
2021
Q2 		$7.78M Sell
15,424
-482
-3% -$227K 3.58% 4
2021
Q1 		$7.26M Buy
15,906
+508
+3% +$242K 3.55% 4
2020
Q4 		$7.17M Sell
15,398
-40
-0.3% -$18.8K 3.83% 3
2020
Q3 		$6.82M Sell
15,438
-592
-4% -$245K 4.38% 3
2020
Q2 		$5.81M Sell
16,030
-165
-1% -$55.3K 4.23% 3
2020
Q1 		$4.59M Buy
16,195
+305
+2% +$96.2K 4.59% 4
2019
Q4 		$5.16M Sell
15,890
-15
-0.1% -$4.55K 3.63% 4
2019
Q3 		$4.63M Sell
15,905
-50
-0.3% -$14.3K 3.67% 5
2019
Q2 		$4.69M Sell
15,955
-420
-3% -$116K 3.54% 5
2019
Q1 		$4.48M Sell
16,375
-4,425
-21% -$1.1M 3.51% 5
2018
Q4 		$4.66M Sell
20,800
-940
-4% -$221K 4.69% 1
2018
Q3 		$5.31M Buy
21,740
+90
+0.4% +$20.7K 3.68% 4
2018
Q2 		$4.49M Sell
21,650
-175
-0.8% -$37.1K 3.35% 5
2018
Q1 		$4.51M Buy
21,825
+525
+2% +$110K 3.35% 7
2017
Q4 		$4.04M Sell
21,300
-135
-0.6% -$25.9K 2.77% 9
2017
Q3 		$4.06M Sell
21,435
-445
-2% -$80.6K 3.41% 6
2017
Q2 		$3.82M Sell
21,880
-475
-2% -$79.8K 2.97% 8
2017
Q1 		$3.43M Sell
22,355
-460
-2% -$70.3K 2.68% 15
2016
Q4 		$3.22M Sell
22,815
-22,085
-49% -$3.26M 2.62% 16
2016
Q3 		$6.89M Buy
44,900
+22,865
+104% +$3.52M 3.07% 6
2016
Q2 		$3.26M Sell
22,035
-1,125
-5% -$166K 2.96% 3
2016
Q1 		$3.28M Sell
23,160
-830
-3% -$111K 3.19% 7
2015
Q4 		$3.4M Buy
23,990
+135
+0.6% +$18K 2.96% 8
2015
Q3 		$2.92M Buy
23,855
+2,175
+10% +$283K 2.86% 13
2015
Q2 		$2.81M Sell
21,680
-150
-0.7% -$19.6K 2.56% 15
2015
Q1 		$2.93M Sell
21,830
-270
-1% -$34.8K 2.62% 15
2014
Q4 		$2.77M Buy
22,100
+855
+4% +$104K 2.49% 17
2014
Q3 		$2.59M Sell
21,245
-275
-1% -$33.4K 2.4% 17
2014
Q2 		$2.54M Sell
21,520
-1,075
-5% -$127K 2.31% 21
2014
Q1 		$2.72M Sell
22,595
-4,650
-17% -$553K 2.55% 13
2013
Q4 		$3.03M Buy
+27,245
New +$2.71M 2.91% 7

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Reliant Investment Management's TMO Position: Q2 2026 in Review

Reliant Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 0.4% in Q2 2026, selling an estimated $23K and leaving 12,047 shares worth $6.04M. The position accounts for 2.15% of the portfolio, ranked #20.

Reliant Investment Management first reported a position in TMO in Q4 2013 and has held it in 51 quarters since. The position peaked at $9.59M in Q4 2021. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Reliant Investment Management held 12,047 shares of Thermo Fisher Scientific worth $6.04M as of Q2 2026.
  • Reliant Investment Management sold 48 Thermo Fisher Scientific shares in Q2 2026, an estimated $23K.
  • Thermo Fisher Scientific made up 2.15% of Reliant Investment Management's portfolio in Q2 2026, its #20 holding.
  • Reliant Investment Management first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 51 quarters since.
  • Reliant Investment Management's Thermo Fisher Scientific position peaked at $9.59M in Q4 2021.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Reliant Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.